Trial Profile
A Phase II Open-label, Parallel Group Study of Abiraterone Acetate Plus Prednisone in African American and Caucasian Men With Metastatic Castrate-resistant Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms Abi Race
- 13 Nov 2019 Status changed from active, no longer recruiting to completed.
- 13 Nov 2019 Planned End Date changed from 1 Oct 2019 to 8 Oct 2019.
- 13 Nov 2019 Planned primary completion date changed from 1 Oct 2018 to 8 Oct 2019.